The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia

Journal Article Corrected proof The Positioning of Ceftobiprole in the Treatment of Staphylococcus aureus Bacteremia Get access Daniel J Minter, Daniel J Minter Division of Infectious Diseases, Department of Medicine, University of California–San Francisco, San Francisco, California, USA Correspondence: D. J. Minter, Division of Infectious Diseases, Department of Medicine, University of California, Room S380, 513 Parnassus Ave, Box 0654, San Francisco, CA 94143, USA (daniel.minter@ucsf.edu). https://orcid.org/0000-0002-4487-934X Search for other works by this author on: Oxford Academic PubMed Google Scholar Ayesha Appa, Ayesha Appa Division of Infectious Diseases, Department of Medicine, University of California–San Francisco, San Francisco, California, USADivision of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California–San Francisco, San Francisco, California, USA https://orcid.org/0000-0002-4602-5954 Search for other works by this author on: Oxford Academic PubMed Google Scholar Henry F Chambers, Henry F Chambers Division of Infectious Diseases, Department of Medicine, University of California–San Francisco, San Francisco, California, USADivision of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, Zuckerberg San Francisco General Hospital, University of California–San Francisco, San Francisco, California, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Sarah B Doernberg Sarah B Doernberg Division of Infectious Diseases, Department of Medicine, University of California–San Francisco, San Francisco, California, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae126, https://doi.org/10.1093/cid/ciae126 Published: 11 March 2024 Article history Published: 11 March 2024 Corrected and typeset: 06 April 2024